ParcelBio

Winter 2024Healthcare -> Therapeuticshttps://parcelbio.com/YC Profile

Next-generation mRNA medicines

Pivot Timeline (0 pivots)

Minor Tweak3/1/202680% confidence

The target customer description is slightly more detailed, and the product category is now a "platform" instead of "technology", but the core offering and target remain the same.

target customer: RNA medicine researchers/developers -> Biotech companies, pharmaceutical companies, and research institutions involved in RNA medicine development
product category: RNA medicine delivery technology -> RNA medicine development platform
Before
Before
After
After

Snapshots (16)

3/1/2026
ok
Screenshot

Headline: ParcelBio

Target: Biotech companies, pharmaceutical companies, and research institutions involved in RNA medicine development

Category: RNA medicine development platform

Problem: ParcelBio aims to advance the development of RNA medicines.

3/1/2026
ok
Screenshot

Headline: ParcelBio

Target: RNA medicine researchers/developers

Category: RNA medicine delivery technology

Problem: ParcelBio aims to deliver the next generation of RNA medicines, presumably solving challenges related to RNA delivery and efficacy.

3/1/2026
ok
Screenshot

H1: ParcelBio

2/20/2026
waybackok

H1: ParcelBio

12/31/2025
waybackok

H1: ParcelBio

11/29/2025
waybackok

H1: ParcelBio

9/6/2025
waybackok

H1: ParcelBio

3/18/2025
waybackok

H1: ParcelBio

3/17/2025
waybackok

H1: ParcelBio

1/17/2025
waybackok

H1: ParcelBio

1/17/2025
waybackok

H1: ParcelBio

1/17/2025
waybackok

H1: ParcelBio

1/14/2025
waybackok

H1: ParcelBio

12/17/2024
waybackok

H1: ParcelBio

9/20/2024
waybackok

H1: ParcelBio

7/4/2024
waybackok

H1: ParcelBio